AAM
GILD icon

Auxier Asset Management’s Gilead Sciences GILD Stock Holding History

Auxier Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.2M Sell
8,616
-177
-2% -$24.8K 0.17% 107
2025
Q4 		$1.08M Sell
8,793
-200
-2% -$24.3K 0.15% 108
2025
Q3 		$998K Sell
8,993
-160
-2% -$18.2K 0.14% 113
2025
Q2 		$1.01M Sell
9,153
-45
-0.5% -$4.79K 0.15% 106
2025
Q1 		$1.03M Sell
9,198
-507
-5% -$52.3K 0.15% 105
2024
Q4 		$896K Sell
9,705
-2,072
-18% -$187K 0.14% 108
2024
Q3 		$987K Sell
11,777
-48
-0.4% -$3.66K 0.15% 109
2024
Q2 		$811K Sell
11,825
-10
-0.1% -$667 0.13% 109
2024
Q1 		$867K Sell
11,835
-382
-3% -$29.4K 0.13% 110
2023
Q4 		$990K Sell
12,217
-366
-3% -$28.5K 0.16% 106
2023
Q3 		$943K Sell
12,583
-220
-2% -$16.9K 0.16% 103
2023
Q2 		$987K Sell
12,803
-35
-0.3% -$2.79K 0.16% 103
2023
Q1 		$1.07M Sell
12,838
-370
-3% -$30.6K 0.18% 100
2022
Q4 		$1.13M Sell
13,208
-30
-0.2% -$2.38K 0.2% 96
2022
Q3 		$817K Sell
13,238
-70
-0.5% -$4.41K 0.16% 103
2022
Q2 		$823K Hold
13,308
– – 0.15% 107
2022
Q1 		$791K Sell
13,308
-150
-1% -$9.59K 0.13% 114
2021
Q4 		$977K Sell
13,458
-490
-4% -$33.7K 0.15% 106
2021
Q3 		$974K Hold
13,948
– – 0.16% 105
2021
Q2 		$960K Sell
13,948
-150
-1% -$10K 0.16% 103
2021
Q1 		$911K Hold
14,098
– – 0.16% 103
2020
Q4 		$821K Sell
14,098
-1,355
-9% -$81.8K 0.15% 103
2020
Q3 		$976K Buy
15,453
+3,703
+32% +$257K 0.2% 95
2020
Q2 		$904K Sell
11,750
-50
-0.4% -$3.83K 0.2% 95
2020
Q1 		$882K Buy
11,800
+1,850
+19% +$128K 0.22% 89
2019
Q4 		$647K Sell
9,950
-100
-1% -$6.51K 0.12% 109
2019
Q3 		$637K Hold
10,050
– – 0.13% 111
2019
Q2 		$679K Sell
10,050
-1,780
-15% -$117K 0.14% 110
2019
Q1 		$769K Buy
11,830
+1,625
+16% +$108K 0.16% 102
2018
Q4 		$638K Sell
10,205
-1,345
-12% -$94K 0.14% 107
2018
Q3 		$892K Buy
11,550
+3,075
+36% +$232K 0.17% 106
2018
Q2 		$600K Buy
8,475
+100
+1% +$7.06K 0.12% 112
2018
Q1 		$631K Buy
8,375
+95
+1% +$7.55K 0.13% 111
2017
Q4 		$593K Buy
8,280
+150
+2% +$11.4K 0.11% 114
2017
Q3 		$659K Buy
8,130
+1,357
+20% +$104K 0.13% 108
2017
Q2 		$479K Buy
6,773
+96
+1% +$6.39K 0.1% 118
2017
Q1 		$454K Buy
6,677
+1,200
+22% +$84.4K 0.1% 118
2016
Q4 		$392K Buy
5,477
+695
+15% +$51.7K 0.09% 122
2016
Q3 		$378K Buy
4,782
+1,800
+60% +$146K 0.08% 123
2016
Q2 		$249K Hold
2,982
– – 0.06% 129
2016
Q1 		$274K Buy
2,982
+700
+31% +$63.1K 0.06% 126
2015
Q4 		$231K Buy
+2,282
New +$237K 0.05% 132

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Auxier Asset Management's GILD Position: Q1 2026 in Review

Auxier Asset Management reduced its Gilead Sciences (GILD) stake by 2% in Q1 2026, selling an estimated $24.8K and leaving 8,616 shares worth $1.2M. The position accounts for 0.17% of the portfolio, ranked #107.

Auxier Asset Management first reported a position in GILD in Q4 2015 and has held it in 42 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Auxier Asset Management held 8,616 shares of Gilead Sciences worth $1.2M as of Q1 2026.
  • Auxier Asset Management sold 177 Gilead Sciences shares in Q1 2026, an estimated $24.8K.
  • Gilead Sciences made up 0.17% of Auxier Asset Management's portfolio in Q1 2026, its #107 holding.
  • Auxier Asset Management first reported a position in Gilead Sciences in Q4 2015 and has held it in 42 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Auxier Asset Management's 13F filing for Q1 2026, filed 14 May 2026.